Azapropazone in the treatment of ankylosing spondylitis: a controlled clinical trial

Rheumatol Rehabil. 1974 Feb;13(1):23-9. doi: 10.1093/rheumatology/13.1.23.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Central Nervous System / drug effects
  • Chemical Phenomena
  • Chemistry
  • Clinical Trials as Topic
  • Digestive System / drug effects
  • Dimethylamines / adverse effects
  • Dimethylamines / therapeutic use
  • Drug Tolerance
  • Female
  • Humans
  • Male
  • Malonates / adverse effects
  • Malonates / therapeutic use
  • Middle Aged
  • Placebos
  • Prognosis
  • Radiography
  • Respiratory System / drug effects
  • Rotation
  • Spine / physiopathology
  • Spondylitis, Ankylosing / diagnostic imaging
  • Spondylitis, Ankylosing / drug therapy*
  • Spondylitis, Ankylosing / physiopathology
  • Triazines / adverse effects
  • Triazines / therapeutic use*

Substances

  • Anti-Inflammatory Agents
  • Dimethylamines
  • Malonates
  • Placebos
  • Triazines